Considering that the differentially expressed genes regulated by TRIM56 knockdown were highly enriched in the Rho GTPase signaling and the motility-promoting effect of TRIM56 on glioma cells, we further assessed the effect of TRIM56 on CDC42 activation. Here, TRIM56 is linked to central nervous system cancer.